| Biological Information | |
|---|---|
| Background Information: | Akt1 is an oncogenic AGC kinase that plays a critical role in regulating many processes including cell survival, metabolism, proliferation, growth and angiogenesis. AKT activation relies on the PI3K pathway, and is recognized as a critical node in the pathway. The E17 hotspot is the most characterized of AKT1 mutations, and has been shown to result in activation of the protein. Mutations in AKT1 have also been shown to confer resistance to allosteric kinase inhibitors in vitro.
GenBank M63167. The recombinant protein contains the amino acid substitution S478G with respect to this accession number. This conflict is reported in EMBL BE 206796. The residue coordinates in the native sequence are given. |
| Target Class: | Kinase |
| Family: | Ser/Thr Kinases: Akt Family |
| Accession Number: | NM_001014431.1; NM_001014432.1; NM_005163.2 |
| Target Name: | Akt1/PKBα |
| Target Aliases: | AKT serine/threonine kinase 1, AKT, PKB, RAC, PRKBA, PKB-ALPHA, RAC-ALPHA |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 6 months at -20°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
Akt1/PKBalpha, unactive
N-terminal 6His-tagged recombinant, human full length Akt1.
Datasheets
14-279x Datasheet
View Document